retinal thickness

Related by string. * Retinal : retinal pigment epithelium RPE . retinal pigment epithelium . inherited retinal . retinal detachment . retinal hemorrhaging . retinal hemorrhages . retinal degeneration / Thickness . THICKNESS : #.#mm thickness [002] . #.#mm thickness [003] . seam thickness . carotid artery thickness . #/#-inch thickness . endometrial thickness . thickness IMT * *

Related by context. Frequent words. (Click for all words.) 65 infarct size 64 virologic response 64 serum phosphorus 63 HbA1c levels 62 LVEF 62 QTc 62 inflammatory lesions 62 glomerular filtration rate 61 albuminuria 61 BCVA 61 preoperatively 61 fasting plasma glucose 61 creatinine clearance 60 intraocular pressure 60 visual acuity 60 neovascularization 60 Secondary endpoints 60 annualized relapse 60 glycated hemoglobin 60 secondary efficacy endpoints 60 symptom severity 60 serum concentrations 60 serum creatinine 60 composite endpoint 59 mg QD 59 HbA1c 59 placebo p 59 plus methotrexate 59 secondary endpoint 59 cerebrovascular events 59 serum uric acid 59 myocardial perfusion 59 postoperatively 58 primary efficacy endpoint 58 plasma concentrations 58 mg BID 58 active comparator 58 adalimumab 58 systolic BP 58 sustained virologic response 58 achieved statistical significance 58 Secondary endpoints included 58 tiotropium 58 mRNA expression 58 Secondary endpoints include 58 microalbuminuria 58 eGFR 57 A1C levels 57 pharmacodynamic 57 hemoglobin concentration 57 mg kg dose 57 echocardiographic 57 mineral density 57 bosentan 57 median PFS 57 laboratory abnormalities 57 secondary endpoints 57 FEV1 57 arterial stiffness 57 Cmax 57 nab paclitaxel 57 fasting blood glucose 57 peginterferon alfa 2a 57 P = .# 57 comorbid conditions 57 DAS# [002] 57 COPAXONE R 57 chemoradiotherapy 57 hemodynamics 56 hypomagnesemia 56 mcg kg 56 tumor shrinkage 56 ADHF 56 RLS symptoms 56 histologically 56 airflow obstruction 56 demonstrated statistically significant 56 nephrectomy 56 prospective randomized controlled 56 C Reactive Protein 56 hemoglobin A1C 56 proteinuria 56 cardiac dysfunction 56 rHuPH# 56 bone resorption 56 mg dose 56 mitral regurgitation 56 prespecified 55 tipranavir 55 renal function 55 PANSS 55 ADAS cog 55 pg mL 55 fasting insulin 55 placebo controlled clinical 55 severe renal impairment 55 azacitidine 55 dose regimens 55 corrected visual acuity 55 cytogenetic response 55 sinus rhythm

Back to home page